Asia-Pacific Molecular Diagnostics Market (2016-2022)

  • ID: 4091257
  • Report
  • 130 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Grifols
  • Qiagen N.V
  • Roche Diagnostics
  • MORE
Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.

Infectious diseases and Cancer is becoming threat for the Asian region specifically India. According to the statistics in 2016, approximately 5.1 million people are living with HIV in Asian region. In 2015, there were an estimated 300,000 new infections in the Asia- Pacific. In Addition, Institute of Medical Research stated the estimation of Cancer, “1.5 lakh breast cancer cases and 1 lakh cervix cancer, new cases were recorded in India”.

Personalized medicine is also becoming trend in medical industry. Food & Drug Administration (FDA) approval for the treatments with tailored medicines is gaining the attention of health professionals and health care manufacturing companies. China has involved in the launch of innovative devices which have techniques for multiple therapeutic areas. Meanwhile, Japan is also launching its new products in vitro diagnostics. Hence, Asia- Pacific is expected to capture largest share in the market owing to increase in infectious diseases and innovation of personalized medicines.

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.

Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into China, India, Japan, Australia, India, South Korea, Singapore, and Rest of Asia-Pacific.

The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Grifols
  • Qiagen N.V
  • Roche Diagnostics
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Molecular Diagnostics Market, by Product & Services
1.4.2 LAMEA Molecular Diagnostics Market, by Technology
1.4.3 LAMEA Molecular Diagnostics Market, by Application
1.4.4 LAMEA Molecular Diagnostics Market, by End User
1.4.5 LAMEA Molecular Diagnostics Market, by Country
1.5 Methodology for the research

2. Executive Summary

3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints

4. LAMEA Molecular Diagnostics Market
4.1 LAMEA Molecular Diagnostics Market by Product & Services
4.1.1 LAMEA Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 LAMEA Molecular Diagnostics Instruments Market by Country
4.1.3 LAMEA Molecular Diagnostics Software & Services Market by Country

5. LAMEA Molecular Diagnostics Market by Technology
5.1 Introduction
5.1.1 LAMEA Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 LAMEA Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 LAMEA Hybridization Molecular Diagnostics Market by Country
5.1.4 LAMEA DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 LAMEA Microarray Molecular Diagnostics Market by Country
5.1.6 LAMEA Other Technologies Market by Country

6. LAMEA Molecular Diagnostics Market by Application
6.1 Introduction
6.1.1 LAMEA Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 LAMEA Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 LAMEA Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 LAMEA Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 LAMEA Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 LAMEA Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 LAMEA Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 LAMEA Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 LAMEA Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 LAMEA Oncology Molecular Diagnostics Market by Country
6.1.4 LAMEA Oncology Molecular Diagnostics Market by Type
6.1.4.1 LAMEA Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 LAMEA Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 LAMEA Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 LAMEA Other Cancers Molecular Diagnostics Market by Country
6.1.5 LAMEA Blood Screening Molecular Diagnostics Market by Country
6.1.6 LAMEA Genetic Tests Molecular Diagnostics Market by Country
6.1.7 LAMEA Microbiology Molecular Diagnostics Market by Country
6.1.8 LAMEA Other Applications Market by Country

7. LAMEA Molecular Diagnostics Market by End User
7.1 Introduction
7.1.1 LAMEA Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 LAMEA Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 LAMEA Molecular Diagnostics Market for Other End Users by Country

8. LAMEA Molecular Diagnostics Market by Country
8.1 Introduction
8.2 Brazil Molecular Diagnostics Market
8.2.1 Brazil Molecular Diagnostics Market by Product & Services
8.2.2 Brazil Molecular Diagnostics Market by Technology
8.2.3 Brazil Molecular Diagnostics Market by Application
8.2.3.1 Brazil Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 Brazil Oncology Molecular Diagnostics Market by Type
8.2.4 Brazil Molecular Diagnostics Market by End User
8.3 Argentina Molecular Diagnostics Market
8.3.1 Argentina Molecular Diagnostics Market by Product & Services
8.3.2 Argentina Molecular Diagnostics Market by Technology
8.3.3 Argentina Molecular Diagnostics Market by Application
8.3.3.1 Argentina Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 Argentina Oncology Molecular Diagnostics Market by Type
8.3.4 Argentina Molecular Diagnostics Market by End User
8.4 UAE Molecular Diagnostics Market
8.4.1 UAE Molecular Diagnostics Market by Product & Services
8.4.2 UAE Molecular Diagnostics Market by Technology
8.4.3 UAE Molecular Diagnostics Market by Application
8.4.3.1 UAE Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 UAE Oncology Molecular Diagnostics Market by Type
8.4.4 UAE Molecular Diagnostics Market by End User
8.5 Saudi Arabia Molecular Diagnostics Market
8.5.1 Saudi Arabia Molecular Diagnostics Market by Product & Services
8.5.2 Saudi Arabia Molecular Diagnostics Market by Technology
8.5.3 Saudi Arabia Molecular Diagnostics Market by Application
8.5.3.1 Saudi Arabia Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 Saudi Arabia Oncology Molecular Diagnostics Market by Type
8.5.4 Saudi Arabia Molecular Diagnostics Market by End User
8.6 South Africa Molecular Diagnostics Market
8.6.1 South Africa Molecular Diagnostics Market by Product & Services
8.6.2 South Africa Molecular Diagnostics Market by Technology
8.6.3 South Africa Molecular Diagnostics Market by Application
8.6.3.1 South Africa Infectious Diseases Molecular Diagnostics Market by Type
8.6.3.2 South Africa Oncology Molecular Diagnostics Market by Type
8.6.4 South Africa Molecular Diagnostics Market by End User
8.7 Nigeria Molecular Diagnostics Market
8.7.1 Nigeria Molecular Diagnostics Market by Product & Services
8.7.2 Nigeria Molecular Diagnostics Market by Technology
8.7.3 Nigeria Molecular Diagnostics Market by Application
8.7.3.1 Nigeria Infectious Diseases Molecular Diagnostics Market by Type
8.7.3.2 Nigeria Oncology Molecular Diagnostics Market by Type
8.7.4 Nigeria Molecular Diagnostics Market by End User
8.8 Rest of LAMEA Molecular Diagnostics Market
8.8.1 Rest of LAMEA Molecular Diagnostics Market by Product & Services
8.8.2 Rest of LAMEA Molecular Diagnostics Market by Technology
8.8.3 Rest of LAMEA Molecular Diagnostics Market by Application
8.8.3.1 Rest of LAMEA Infectious Diseases Molecular Diagnostics Market by Type
8.8.3.2 Rest of LAMEA Oncology Molecular Diagnostics Market by Type
8.8.3.3 Rest of LAMEA Molecular Diagnostics Market by End User

9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Qiagen N.V
  • Roche Diagnostics
  • Grifols
  • Siemens Healthcare (Siemens AG)
  • Becton Dickinson and Company
  • Danaher Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll